Amonkar et al. identified an 11-plex protein panel including: CA-125, CA 19-9, soluble epidermal growth factor receptor (EGFR), C-reactive protein, myoglobin, apolipoprotein A1 (APOA1), APOC3, macrophage inhibitory protein 1 (MIP-1), interleukin-6 and 18 (IL6 and IL18), and tenascin C. These authors built microarrays bearing this panel of proteins to analyze plasma samples and discussed their applicability to distinguish patients with ovarian cancer from controls [32]. The gene discussed is APOA1; the disease is ovarian cancer.